RCEL - AVITA Medical to Announce Third Quarter 2023 Financial Results | Benzinga
VALENCIA, Calif., Oct. 19, 2023 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ:RCEL, ASX: AVH)), a regenerative medicine company leading the development and commercialization of first-in-class devices and autologous cellular therapies for skin restoration, today announced that it will report its third quarter 2023 financial results after the close of the U.S. financial markets on Thursday, November 9, 2023. AVITA Medical will host a conference call and webcast that day at 1:30 p.m. Pacific Time (Friday, November 10, 2023, at 7:30 a.m. Australian Eastern Daylight Time) to discuss its financial results and recent business highlights.
To access the live call via telephone, please register in advance using the ...